Literature DB >> 3749242

Action of vinca alkaloides on calcium movements through mitochondrial membrane.

C Tari, N Fournier, C Briand, G Ducet, A Crevat.   

Abstract

The antimitotic drugs Vinblastine and Vincristine partially counteract the decoupling effect of both calcium ionophore and Ca2+ on mitochondria. The partial restoration of respiratory control is mainly due to an action on oxidative rate in state 4. In the same manner the P/O ratio is partially restorated. Moreover Vinca alkaloides decrease both the calcium uptake rate and its amount into mitochondria during aerobiosis and slacken the calcium efflux. These results may be explained by a non specific effect of Vinca alkaloides on mitochondrial membrane and might lead to a change in cytoplasmic Ca2+ concentration. Recently, calcium influx blockers (calcium antagonists) have appeared to enhance the cytotoxicity of Vinca alkaloides and to circumvent the Vincristine resistance of some tumor cells (Takashi Tsuruo et al. 1981, 1983). Besides, ruthenium red is a membrane inorganic dye known to bind and inhibit some calcium carriers (mitochondrial carrier, ATP ase calcium dependent from sarcoplasmic reticulum and erythrocyte). This dye has proved to increase the Vinblastine cell accumulation and its toxicity on cells culture (Wilberding C. 1984). So calcium might be involved in the therapeutic activity of Vinca alkaloides. Therefore, in order to investigate this possible implication we studied the effect of these drugs on calcium movements in mitochondria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749242     DOI: 10.1016/0031-6989(86)90147-5

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  8 in total

1.  Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy.

Authors:  Chiang Siau; Gary J Bennett
Journal:  Anesth Analg       Date:  2006-05       Impact factor: 5.108

Review 2.  Interphase microtubules: chief casualties in the war on cancer?

Authors:  Angela Ogden; Padmashree C G Rida; Michelle D Reid; Ritu Aneja
Journal:  Drug Discov Today       Date:  2013-11-04       Impact factor: 7.851

Review 3.  Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.

Authors:  Jiacheng Ma; Annemieke Kavelaars; Patrick M Dougherty; Cobi J Heijnen
Journal:  Cancer       Date:  2018-02-20       Impact factor: 6.860

4.  Assessment of genotoxicity of vincristine, vinblastine and vinorelbine in human cultured lymphocytes: a comparative study.

Authors:  N M Mhaidat; K H Alzoubi; O F Khabour; K Z Alawneh; L A Raffee; E S Alsatari; E I Hussein; K E Bani-Hani
Journal:  Balkan J Med Genet       Date:  2016-08-02       Impact factor: 0.519

5.  Ameliorative potential of Alstonia scholaris (Linn.) R. Br. against chronic constriction injury-induced neuropathic pain in rats.

Authors:  Hasandeep Singh; Rohit Arora; Saroj Arora; Balbir Singh
Journal:  BMC Complement Altern Med       Date:  2017-01-19       Impact factor: 3.659

Review 6.  Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.

Authors:  Nicolas Kerckhove; Aurore Collin; Sakahlé Condé; Carine Chaleteix; Denis Pezet; David Balayssac
Journal:  Front Pharmacol       Date:  2017-02-24       Impact factor: 5.810

7.  Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review.

Authors:  Tyler C Alexander; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2021-08-03       Impact factor: 9.052

Review 8.  Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Authors:  Annalisa Canta; Eleonora Pozzi; Valentina Alda Carozzi
Journal:  Toxics       Date:  2015-06-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.